WO2014042670A1 - Technique for determining optimum treatment parameters - Google Patents
Technique for determining optimum treatment parameters Download PDFInfo
- Publication number
- WO2014042670A1 WO2014042670A1 PCT/US2013/000211 US2013000211W WO2014042670A1 WO 2014042670 A1 WO2014042670 A1 WO 2014042670A1 US 2013000211 W US2013000211 W US 2013000211W WO 2014042670 A1 WO2014042670 A1 WO 2014042670A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- location
- electrodes
- series
- treatments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36031—Control systems using physiological parameters for adjustment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
- A61B5/4035—Evaluating the autonomic nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36135—Control systems using physiological parameters
Definitions
- This invention relates to a method and apparatus for determining effective treatment parameters in an electrical interferential system.
- the responses of the patient may be entered into software designed to obtain better parameters.
- the software may contain a series of logic circuits which may be briefly described as an effort to determine whether the patient experiences improved blood flow in response to the application of a series of treatment parameters.
- One broad manner of intended use of the disclosed technique is for the patient to be initially treated by professionals in a professional setting where a first set of treatment parameters is obtained and a first treatment delivered " to the " patient. Many subsequent treatments may be conducted by the patient or caregiver at a location other than a professional office, such as at the patient's residence. In order to run subsequent treatments, a new set of treatment parameters may preferably be obtained by the device using the same device and software.
- the hardware and software obtain, in an automated way, the patient's response to a series of treatment parameters and saves or stores the patient's responses to the parameters, typically on an electronic storage medium, along with the parameters, the time and manner the parameters were determined and other pertinent information. Similarly, the time and parameters used in a treatment may also be saved or stored.
- a communications link may be provided to allow a professional to check on whether the treatment parameters were selected in an appropriate manner. Similarly, the communications link may be used to allow a professional to check on whether the treatments were in fact done and done in a manner and at a time consistent with best practice.
- Figure 1 is a flow chart of an automated parameter selection technique
- Figure 2 is a combined schematic view of a diagnostic system and a pictorial view of the application of electrodes to a patient in accordance;
- Figure 3 is a view of a finger tip temperature sensor
- Figure 4 is a schematic view of one embodiment of a communications link.
- Figure 5 is a schematic view of another embodiment of the disclosed technique.
- electrical energy in the form of electrical interferential pulses are delivered into the patient' s body. These treatments cause change in the patient which is monitored by the disclosed device.
- the effect of the electrical interferential pulses is monitored by one or more sensors that detect a function or an aspect of the autonomic nervous system.
- the sensed changes in the patient are then used to modify the output of the treatment unit and/or the placement of the electrodes used by the treatment machine.
- the results of the tests are used in an attempt to determine a preferred way to treat the patient by adjusting the treatment machine in response to the tests results.
- a healthy organism is capable of quickly adjusting to many external influences because of an adequate sympathetic response.
- an overly active sympathetic nervous system tends to create or accentuate such diverse conditions or ailments such as diabetes type 1 and type 2, fibromyalgia, bipolar disorder, endometriosis, hypertension and other ailments such as disclosed in Application S.N. 11/326,230, filed January 5, 2006 or those ailments disclosed in U.S. Patent 5,995,873.
- a wide variety of techniques may be used to monitor the autonomic nervous system and thereby determine the effect of an interferential treatment on the patient.
- a preferred technique is to monitor finger tip temperature because the response is relatively rapid, easy to measure and is relatively unambiguous.
- other manifestations of the autonomic nervous system may be monitored, for example, skin resistivity, pulse rate, blood pressure, iris pupil diameter, respiration rate, or any other indicator of autonomic nervous system function.
- a patient 10 is hooked up to an electrical interferential therapy device 12 inside a housing 14.
- the electrical interferential therapy device 12 may include a ore- or-less conventional treatment module 16 such as is commercially available from Dynatronics, Inc. of Salt Lake City, Utah, to which reference is made for a more complete description thereof and as explained more fully hereinafter.
- the reaction of the patient 10 is monitored by one or more sensors 18, 20 which may preferably be a digital temperature sensor incorporated into a spring biased clip which may attach to a finger or toe on each side of the patient.
- Each sensor 18, 20 may be connected by a wire 22, 24 to a module 28 in the housing 14.
- the module 28 may be a data processor to record the temperature sensings from the sensors 18, 20, store the values in a memory module 30, control the treatment module 16 and otherwise operate the device 12.
- the memory module 30 may be removable from the housing 14 for purposes more fully explained hereinafter.
- the housing 14 may include a pair of receptacles 32, 34 capable of accepting a jack 36, 38 of insulated wire pairs 40, 42 leading to electrode pairs 44, 44 ' and 46, 46'.
- a suitable display 48 provides readings such as values from the sensors 18, 20, the carrier frequency, the pulse frequency being tested, the time and date of the procedure and any other desirable information, such as the intensity of treatment, time left to finish the treatment, time elapsed during a particular testing cycle, results of testing sequences, and whether it is time to replace the electrodes.
- Standard commercially available electrical interference treatment devices have either a fixed carrier frequency or a minimally selective carrier frequency.
- these frequencies are conventionally 1850 Hz and 2850 Hz in the Sympathetic Therapy System from Dynatronics, Inc. and 4000 Hz in a device commercially available by Rehabilicare Corporation of St. Paul, Minnesota.
- the carrier frequency may be either fixed or variable.
- the device 12 may include a select actuator 50 and up/down actuators 52, 54. It is sometimes desirable to increase the intensity of the electrical pulses. Assuming the actuator 52 to increase intensity, it may be manually depressed and an intensity value may be displayed on the screen 48. When the desired intensity value shows on the screen 48, the select actuator 50 may be depressed to instruct the module 28 to increase the intensity to the selected value.
- the module 28 may provide other functions. For example, the electrodes 44, 44 ', 46, 46' don't provide good sensings indefinitely. The module 28 may run tests to determine whether the electrodes need to be replaced, may count the number of treatments or the number of parameter determining trials are run and display a message on the screen 48 to replace the electrodes.
- the select actuator 50 may be depressed to send a message to the module 28 that the electrodes have been or will be changed.
- the device 12 may also include a timer function and the time of and duration of treatments and/or the acquisition of treatment parameters.
- the device 12 may also include an on-off switch 56.
- the carrier and beat frequencies used in selecting treatment parameters may be selected by the actuators 50, 52, 54 or default selections may be provided by software in the processor 28.
- the vast majority of desirable beat frequencies are between 1-150 beats per second (bps) although current commercially available devices only employ 1-80 beats per second. In attempts to find the most desirable beat frequency in a reasonable time frame, this range has been subdivided into smaller segments.
- the device 12 includes a circuit for delivering therapeutic electrical energy into the body of the patient and more particularly includes a subcircuit for modifying the carrier frequency, the beat frequency and/or the amplitude of alternating current type energy.
- the first thing that may be done is to allow or insure that the finger tip temperature of the patient has stabilized.
- the patient's finger temperatures often change in response to room temperature and it may be desirable to allow them to cease responding to room temperature. This may be done by measuring the initial temperature of the patient's finger tips and determining whether the temperature is varying over time. At the end of a short specified period, e.g. one minute, a determination is made whether finger tip temperature has stabilized by comparing initial and subsequent temperatures.
- a suitable set of parameters is that when finger tip temperature changes less than 1°F in one minute, the processor 28 determines that temperature has stabilized and the acquisition of treatment parameters continues in accordance with Figure 1 .
- the electrodes are attached to the patient' s skin in a conventional manner, i.e. they may be self adherent.
- the location of the electrodes on the patient establish the electrical circuit in the patient' s body.
- one electrode 44 is placed adjacent the end or terminus of the right medial plantar nerve L5 and its matching electrode or mate 44' is placed adjacent the end or terminus of the left sural nerve SI, inferior to the left ankle bone (lateral malleolus) thereby establishing or creating a first circuit 58 in the patient' s body.
- the reference characters L5 , SI and the like are standard medical terminology for the nerve. Those skilled in the art will recognize L5 as being the nerve which extends away from the fifth lumbar vertebra and SI as being the nerve which extends away from the first sacral vertebra.
- the electrode pattern illustrated in Figure 2 and as described is shown in U.S. Patent 5,995,873. It will be understood that there are hundreds or thousands of potential electrode patterns.
- a preferred approach may be to employ an additional four electrodes for a total of eight electrodes.
- the additional electrodes may be placed in any suitable manner, such as in a L4-S2, L5-L4 pattern or in acupuncture sites on the feet.
- the terminus of the right medial plantar nerve L5 is located on the bottom of the right foot, approximately on the ball of the foot.
- the terminus of the left sural nerve SI is located below the left ankle bone (lateral malleolus) .
- Another electrode 46 is placed adjacent the terminus of the right sural nerve SI and its matching electrode or mate 46' is placed adjacent the terminus of the left medial plantar nerve L5 thereby establishing a second circuit 60 in the patient' s body. Turning the device 12 on delivers electrical energy through the circuits 58, 60.
- the medial plantar nerves L5 and the sural nerves SI terminate adjacent the spinal column near adjacent spinal vertebra, in the area of the connection to the lumbar sympathetic ganglia.
- the sensor 18 may include a pair of clip sections 62, 64 connected for pivotal movement about an axis 66.
- a spring biases the sections 62, 64 together.
- An infrared temperature sensor (not shown) or other suitable temperature measuring device is incorporated into one or the other of the clip sections 62, 64.
- an infrared sensor (not shown) may be exposed on the housing 14 so the patient simply places finger tips on the housing 14.
- the patient is briefly subjected to no carrier frequency or frequencies or beat frequency or frequencies for a short period, typically about five minutes, in order to allow the thermistors to equilibrate to the finger temperature.
- the patient is subjected to a series of tests, initially using different beat frequencies in an attempt to determine an effective, optimum or ideal combination of parameters that produce a desired effect on the autonomic nervous system and thereby determine a preferred treatment regimen.
- This may be accomplished by using one of the carrier frequencies and delivering a series of pulses in a first range, such as l-io pulses/second, while sensing and recording the temperature measured by the sensors 18, 20.
- the sequence of delivering the pulses may be in any suitable manner.
- the standard interferential module 16 produces a sweep of beats in this range in the following repeating pattern: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1, changing every second.
- the finger tip temperature may be recorded continuously or at any suitable interval, e.g. one minute.
- a hypothetical temperature pattern conducted on a female having an original left finger tip temperature of 71.2°F and an original right finger tip temperature of 72.6°F is shown in Table I
- the purpose of the trial is to determine parameters that produce a significant increase in digit temperature based on the premise that this is a proxy for improved blood circulation.
- Table I shows a situation where the subject's finger tip temperature increased about 0.3°F in three minutes. This suggests a minimal increase in blood circulation so software in the processor module 28 concludes the selected pulse beat frequency and electrode placement is ineffective .
- the module 28 accordingly writes onto the memory module 30 information relevant to the trial, e.g. the serial number of the device 12, the time and date of the trial, and all of the data created during the testing and running of the treatment onto the memory module 30.
- a second trial may commence using a different pulse frequency, e.g. 11-20 beats per second. This process repeats until a temperature increase above some minimum, which is preferably at least l°F in a few minutes such as three or four minutes, is attained or until some maximum range is reached. If there is no successful trial after trying each ten pulse range through the maximum range, a message appears on the display 48 to try a different electrode pattern and/or a different carrier frequency. The process is repeated until a satisfactory temperature increase is obtained. All of the trial parameters and trial results are written onto the memory module 30.
- a different pulse frequency e.g. 11-20 beats per second.
- the selected treatment may be delivered to the patient in response to a message on the display 48 or automatically.
- the patient, caregiver or professional may instruct the device 12 to apply the treatment by depressing the select actuator 50. If, having tested all of the beat frequency permutations available, no combination is able to create an adequate thermistor temperature increase indicating an adequate circulation increase, the beat frequency combination which created the highest increase will be utilized for the treatment.
- a message appears on the display 48 saying "new protocol needed" or other similar message advising the clinician or patient that a different electrode placement is needed.
- the message may indicate that the professional be contacted to determine another electrode pattern or that a reference book or data base be used to determine another electrode pattern.
- the memory module 30 provides an important advantage. There are situations where the patient or patient's caregiver is conducting trials to determine suitable parameters and then delivering treatments at a location away from the professional's office, e.g. at the patient's residence. In this situation, it is very desirable to have the capability of reviewing the trial procedures and results.
- the module 30 may be removed and placed in a computer 68 where data from the module 30 may be transmitted through a communication link 70 to the professional's office 72 where the data can be stored on a computer 74, retrieved and viewed ( Figure 4). In this manner, the professional can determine from a location remote from the patient whether the parameter determining trials were run and run correctly.
- the communications link 64 may be of any suitable type, such as by an Internet connection.
- the communication link 70 also allows the professional to review whether, when and how treatments were conducted because treatment information, as well as parameter acguisition information, is written onto and stored on the memory module 30. Thus, treatment information as well as parameter information may be transmitted to the professional.
- an interferential device 76 including an interferential treatment module 78 and a processor module 80 which includes all of the functions of the processor 28 and a communication module 82 providing a communication link 84 directly with a computer 86 in a professional's office 88.
- the communication link 84 may be of any suitable type, such as a cell phone, Internet connection or the like. It will be seen that the interferential device 76 transmits parameter determining information as well as treatment information to the computer 86 so it may be reviewed for accuracy and timeliness .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Physiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Pain & Pain Management (AREA)
- Electrotherapy Devices (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2015003264A MX364347B (en) | 2012-09-17 | 2013-09-13 | Technique for determining optimum treatment parameters. |
GB1506377.9A GB2520907B (en) | 2012-09-17 | 2013-09-13 | A system for determining and applying treatment parameters for an electrical interferential treatment regime |
JP2015531904A JP6226989B2 (en) | 2012-09-17 | 2013-09-13 | Optimal treatment parameter judgment method |
AU2013316101A AU2013316101B2 (en) | 2012-09-17 | 2013-09-13 | Technique for determining optimum treatment parameters |
CA2923230A CA2923230C (en) | 2012-09-17 | 2013-09-13 | Technique for determining optimum treatment parameters |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261744085P | 2012-09-17 | 2012-09-17 | |
US61/744,085 | 2012-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014042670A1 true WO2014042670A1 (en) | 2014-03-20 |
Family
ID=50278582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/000211 WO2014042670A1 (en) | 2012-09-17 | 2013-09-13 | Technique for determining optimum treatment parameters |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP6226989B2 (en) |
AU (1) | AU2013316101B2 (en) |
CA (1) | CA2923230C (en) |
GB (1) | GB2520907B (en) |
MX (1) | MX364347B (en) |
WO (1) | WO2014042670A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107209795A (en) * | 2014-12-17 | 2017-09-26 | 皇家飞利浦有限公司 | Mobile health care center |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4580569A (en) * | 1983-12-15 | 1986-04-08 | Wright State University | Apparatus and method for muscle stimulation |
US5512057A (en) * | 1994-11-14 | 1996-04-30 | Medserv Group, Inc. | Interferential stimulator for applying localized stimulation |
US20060052844A1 (en) * | 2004-09-02 | 2006-03-09 | Tom Newman | System and method for measuring modifying and reporting treatment compliance |
US20070150029A1 (en) * | 2005-12-02 | 2007-06-28 | Medtronic, Inc. | Closed-loop therapy adjustment |
US20070219598A1 (en) * | 2006-03-14 | 2007-09-20 | Rhodes Donald A | Diagnostic method and apparatus |
US20080167573A1 (en) * | 2002-08-22 | 2008-07-10 | John Stivoric | Systems, methods, and devices to determine and predict physilogical states of individuals and to administer therapy, reports, notifications, and the like therefor |
US20080255471A1 (en) * | 2002-08-23 | 2008-10-16 | Endothelix, Inc. | Method and apparatus for determining vascular health conditions |
US20110152974A1 (en) * | 2001-10-23 | 2011-06-23 | The Cleveland Clinic Foundation | Methods of treating medical conditions by neuromodulation of the sympathetic nervous system |
US20110313488A1 (en) * | 2010-06-16 | 2011-12-22 | Juan Gabriel Hincapie Ordonez | Automatic neural stimulation titration sweep |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3569247B2 (en) * | 2001-09-28 | 2004-09-22 | 株式会社東芝 | Biological information measuring device and health management system |
JP4031719B2 (en) * | 2003-03-06 | 2008-01-09 | ヒロセ電機株式会社 | Interference low frequency treatment device |
JP2008500113A (en) * | 2004-05-26 | 2008-01-10 | エンドテリックス,インコーポレイテッド | Method and apparatus for determining health conditions |
US8515551B2 (en) * | 2006-03-14 | 2013-08-20 | Donald A. Rhodes | Diagnostic method and apparatus |
US7991476B2 (en) * | 2006-05-22 | 2011-08-02 | Empire Bio-Medical Devices, Inc. | Method and device for enhanced blood flow |
US20080021287A1 (en) * | 2006-06-26 | 2008-01-24 | Woellenstein Matthias D | System and method for adaptively adjusting patient data collection in an automated patient management environment |
WO2009138880A2 (en) * | 2008-05-12 | 2009-11-19 | Cardio Art Technologies, Ltd. | Optical sensor apparatus and method of using same |
JP2012070777A (en) * | 2010-09-27 | 2012-04-12 | Ito Chotanpa Kk | Therapeutic apparatus, and signal generating method |
-
2013
- 2013-09-13 WO PCT/US2013/000211 patent/WO2014042670A1/en active Application Filing
- 2013-09-13 AU AU2013316101A patent/AU2013316101B2/en active Active
- 2013-09-13 CA CA2923230A patent/CA2923230C/en active Active
- 2013-09-13 MX MX2015003264A patent/MX364347B/en active IP Right Grant
- 2013-09-13 GB GB1506377.9A patent/GB2520907B/en active Active
- 2013-09-13 JP JP2015531904A patent/JP6226989B2/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4580569A (en) * | 1983-12-15 | 1986-04-08 | Wright State University | Apparatus and method for muscle stimulation |
US5512057A (en) * | 1994-11-14 | 1996-04-30 | Medserv Group, Inc. | Interferential stimulator for applying localized stimulation |
US20110152974A1 (en) * | 2001-10-23 | 2011-06-23 | The Cleveland Clinic Foundation | Methods of treating medical conditions by neuromodulation of the sympathetic nervous system |
US20080167573A1 (en) * | 2002-08-22 | 2008-07-10 | John Stivoric | Systems, methods, and devices to determine and predict physilogical states of individuals and to administer therapy, reports, notifications, and the like therefor |
US20080255471A1 (en) * | 2002-08-23 | 2008-10-16 | Endothelix, Inc. | Method and apparatus for determining vascular health conditions |
US20060052844A1 (en) * | 2004-09-02 | 2006-03-09 | Tom Newman | System and method for measuring modifying and reporting treatment compliance |
US20070150029A1 (en) * | 2005-12-02 | 2007-06-28 | Medtronic, Inc. | Closed-loop therapy adjustment |
US20070219598A1 (en) * | 2006-03-14 | 2007-09-20 | Rhodes Donald A | Diagnostic method and apparatus |
US20110313488A1 (en) * | 2010-06-16 | 2011-12-22 | Juan Gabriel Hincapie Ordonez | Automatic neural stimulation titration sweep |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107209795A (en) * | 2014-12-17 | 2017-09-26 | 皇家飞利浦有限公司 | Mobile health care center |
JP2018500090A (en) * | 2014-12-17 | 2018-01-11 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Mobile health care hub |
Also Published As
Publication number | Publication date |
---|---|
GB2520907A (en) | 2015-06-03 |
AU2013316101A1 (en) | 2015-05-07 |
CA2923230A1 (en) | 2014-03-20 |
JP6226989B2 (en) | 2017-11-08 |
GB2520907B (en) | 2019-09-04 |
JP2015528371A (en) | 2015-09-28 |
MX364347B (en) | 2019-04-23 |
CA2923230C (en) | 2022-08-09 |
GB201506377D0 (en) | 2015-05-27 |
MX2015003264A (en) | 2015-07-06 |
AU2013316101B2 (en) | 2018-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021203764B2 (en) | Systems and methods for performing neurophysiologic monitoring during spine surgery | |
EP2097056B1 (en) | Electrotherapeutic device | |
EP2318093B1 (en) | Systems for automated muscle stimulation | |
US9630003B2 (en) | Non-invasive neuro stimulation system | |
JP6012466B2 (en) | Magnetic stimulation device and method | |
KR101929720B1 (en) | Dysphagia test device, dysphagia test method, dysphagia treatment device and stimulation current setting method | |
US20150230749A1 (en) | Systems and methods for performing neurophysiologic monitoring during spine surgery | |
US20070293917A1 (en) | Non-invasive neuro stimulation system | |
US9333348B2 (en) | Apparatus for determining optimum treatment parameters | |
US20190134382A1 (en) | Method and system for adjusting stimulation therapy | |
AU2013316101B2 (en) | Technique for determining optimum treatment parameters | |
US20190059809A1 (en) | Method and apparatus for determining a pain threshold of a subject | |
JP2020137541A (en) | Data creation device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13836896 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2015531904 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2015/003264 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 1506377 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20130913 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1506377.9 Country of ref document: GB |
|
ENP | Entry into the national phase |
Ref document number: 2013316101 Country of ref document: AU Date of ref document: 20130913 Kind code of ref document: A |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13836896 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2923230 Country of ref document: CA |